Studies have documented increased CD69+ T cells in the palatine tonsils and cervical lymph nodes of stroke patients 76 h following stroke onset [80], and that activated T cells reactive to myelin oligodendrocyte glycoprotein accumulate in the brain following experimental stroke, implicating activated T cells in driving autoimmunity post‐stroke [81, 82]. Here, CD69 is linked to stroke disorder.